SHARPS TECHNOLOGY INC (STSS) Fundamental Analysis & Valuation
NASDAQ:STSS • US82003F3091
Current stock price
1.84 USD
+0.06 (+3.08%)
At close:
1.83 USD
-0.01 (-0.54%)
After Hours:
This STSS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. STSS Profitability Analysis
1.1 Basic Checks
- In the past year STSS was profitable.
- In the past year STSS has reported a negative cash flow from operations.
- STSS had negative earnings in each of the past 5 years.
- In the past 5 years STSS always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -104.99%, STSS is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
- The Return On Equity of STSS (-106.85%) is worse than 65.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -104.99% | ||
| ROE | -106.85% | ||
| ROIC | N/A |
ROA(3y)-105.19%
ROA(5y)-86.75%
ROE(3y)-232.2%
ROE(5y)-178.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- STSS has a Gross Margin of 91.19%. This is amongst the best in the industry. STSS outperforms 96.79% of its industry peers.
- STSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 91.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. STSS Health Analysis
2.1 Basic Checks
- STSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for STSS has been increased compared to 1 year ago.
- Compared to 5 years ago, STSS has more shares outstanding
- The debt/assets ratio for STSS has been reduced compared to a year ago.
2.2 Solvency
- STSS has an Altman-Z score of 6.12. This indicates that STSS is financially healthy and has little risk of bankruptcy at the moment.
- STSS has a Altman-Z score of 6.12. This is amongst the best in the industry. STSS outperforms 80.21% of its industry peers.
- A Debt/Equity ratio of 0.01 indicates that STSS is not too dependend on debt financing.
- The Debt to Equity ratio of STSS (0.01) is better than 71.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.12 |
ROIC/WACCN/A
WACC8.8%
2.3 Liquidity
- STSS has a Current Ratio of 4.02. This indicates that STSS is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 4.02, STSS is in the better half of the industry, outperforming 64.17% of the companies in the same industry.
- STSS has a Quick Ratio of 3.88. This indicates that STSS is financially healthy and has no problem in meeting its short term obligations.
- STSS's Quick ratio of 3.88 is fine compared to the rest of the industry. STSS outperforms 71.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.02 | ||
| Quick Ratio | 3.88 |
3. STSS Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 101.69% over the past year.
EPS 1Y (TTM)101.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. STSS Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 0.05, the valuation of STSS can be described as very cheap.
- STSS's Price/Earnings ratio is rather cheap when compared to the industry. STSS is cheaper than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.64, STSS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.05 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. STSS Dividend Analysis
5.1 Amount
- STSS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
STSS Fundamentals: All Metrics, Ratios and Statistics
1.84
+0.06 (+3.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength16.77
Industry Growth32.3
Earnings (Last)03-31 2026-03-31
Earnings (Next)N/A N/A
Inst Owners27.14%
Inst Owner Change0%
Ins Owners0.09%
Ins Owner Change0%
Market Cap71.13M
Revenue(TTM)7.01M
Net Income(TTM)-282.50M
Analysts82.86
Price Target22.44 (1119.57%)
Short Float %1.71%
Short Ratio1.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-99.46%
Min Revenue beat(2)-99.56%
Max Revenue beat(2)-99.36%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.05 | ||
| Fwd PE | N/A | ||
| P/S | 10.15 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.27 | ||
| P/tB | 0.27 | ||
| EV/EBITDA | N/A |
EPS(TTM)35.49
EY1928.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.18
BVpS6.84
TBVpS6.84
PEG (NY)N/A
PEG (5Y)N/A
Graham Number73.8972 (3916.15%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -104.99% | ||
| ROE | -106.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 91.19% | ||
| FCFM | N/A |
ROA(3y)-105.19%
ROA(5y)-86.75%
ROE(3y)-232.2%
ROE(5y)-178.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.02 | ||
| Quick Ratio | 3.88 | ||
| Altman-Z | 6.12 |
F-Score5
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1365.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-133.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-138.4%
OCF growth 3YN/A
OCF growth 5YN/A
SHARPS TECHNOLOGY INC / STSS Fundamental Analysis FAQ
What is the fundamental rating for STSS stock?
ChartMill assigns a fundamental rating of 2 / 10 to STSS.
What is the valuation status of SHARPS TECHNOLOGY INC (STSS) stock?
ChartMill assigns a valuation rating of 2 / 10 to SHARPS TECHNOLOGY INC (STSS). This can be considered as Overvalued.
How profitable is SHARPS TECHNOLOGY INC (STSS) stock?
SHARPS TECHNOLOGY INC (STSS) has a profitability rating of 1 / 10.
How financially healthy is SHARPS TECHNOLOGY INC?
The financial health rating of SHARPS TECHNOLOGY INC (STSS) is 5 / 10.